Joris Verlooy

789 total citations
26 papers, 457 citations indexed

About

Joris Verlooy is a scholar working on Neurology, Pediatrics, Perinatology and Child Health and Genetics. According to data from OpenAlex, Joris Verlooy has authored 26 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 8 papers in Pediatrics, Perinatology and Child Health and 5 papers in Genetics. Recurrent topics in Joris Verlooy's work include Neuroblastoma Research and Treatments (6 papers), Childhood Cancer Survivors' Quality of Life (4 papers) and Glioma Diagnosis and Treatment (4 papers). Joris Verlooy is often cited by papers focused on Neuroblastoma Research and Treatments (6 papers), Childhood Cancer Survivors' Quality of Life (4 papers) and Glioma Diagnosis and Treatment (4 papers). Joris Verlooy collaborates with scholars based in Belgium, Netherlands and France. Joris Verlooy's co-authors include Yves Benoît, Liesbet Goubert, Tine Vervoort, Line Caes, Jean‐Jacques Martin, P J Willems, Erna Dams, Luc Heytens, Hugo Robays and Tiene Bauters and has published in prestigious journals such as PEDIATRICS, European Journal of Cancer and Journal of Endocrinology.

In The Last Decade

Joris Verlooy

24 papers receiving 445 citations

Peers

Joris Verlooy
Klaus Gasser Austria
Kari Bjornard United States
Stephen Done United States
Lane Faughnan United States
R. Fischer Germany
Klaus Gasser Austria
Joris Verlooy
Citations per year, relative to Joris Verlooy Joris Verlooy (= 1×) peers Klaus Gasser

Countries citing papers authored by Joris Verlooy

Since Specialization
Citations

This map shows the geographic impact of Joris Verlooy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joris Verlooy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joris Verlooy more than expected).

Fields of papers citing papers by Joris Verlooy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joris Verlooy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joris Verlooy. The network helps show where Joris Verlooy may publish in the future.

Co-authorship network of co-authors of Joris Verlooy

This figure shows the co-authorship network connecting the top 25 collaborators of Joris Verlooy. A scholar is included among the top collaborators of Joris Verlooy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joris Verlooy. Joris Verlooy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Joachim, Luc Deliëns, Marijke C. Kars, et al.. (2025). Multi-center randomized controlled trial on advance care planning for adolescents with cancer and their parents: Impact on parent-adolescent communication. European Journal of Oncology Nursing. 75. 102823–102823.
2.
Boudewyns, An, et al.. (2022). Effectiveness of nitrous oxide sedation for otolaryngologic examination in the outpatient clinic in uncooperative children. International Journal of Pediatric Otorhinolaryngology. 162. 111328–111328. 2 indexed citations
3.
Verlooy, Joris, et al.. (2022). A case report of a novel NTRK gene fusion in pleomorphic xanthoastrocytoma. Clinical Neuropathology. 41(9). 233–235. 1 indexed citations
4.
Messiaen, Julie, Alina Ferster, Caroline Piette, et al.. (2021). Retrospective study of diffuse intrinsic pontine glioma in the Belgian population: a 25 year experience. Journal of Neuro-Oncology. 153(2). 293–301. 5 indexed citations
5.
Heerden, Jaques van, et al.. (2020). Primary Thyroid Lymphoma in an Adolescent with Hashimoto’s Thyroiditis and Congenital Deafness. 1–5. 1 indexed citations
6.
Anguille, Sébastien, Joris Verlooy, Evelien Smits, et al.. (2019). Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer. Cancers. 11(9). 1396–1396. 14 indexed citations
7.
Vanhoenacker, Filip, et al.. (2018). Spontaneous resolution of unifocal Langerhans cell histiocytosis of the skull: potential role of ultrasound in detection and imaging follow-up. Journal of Ultrasonography. 18(74). 265–270. 5 indexed citations
8.
Caes, Line, Liesbet Goubert, Paul Devos, et al.. (2014). The Relationship Between Parental Catastrophizing About Child Pain and Distress in Response to Medical Procedures in the Context of Childhood Cancer Treatment: A Longitudinal Analysis. Journal of Pediatric Psychology. 39(7). 677–686. 29 indexed citations
9.
Grill, Jacques, Birgit Geoerger, Danuta Perek, et al.. (2013). Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study. Neuro-Oncology. 15(9). 1236–1243. 29 indexed citations
10.
Caes, Line, et al.. (2013). Parental Distress and Catastrophic Thoughts About Child Pain. Clinical Journal of Pain. 30(9). 787–799. 49 indexed citations
11.
Bauters, Tiene, Joris Verlooy, Hugo Robays, Yves Benoît, & Geneviève Laureys. (2013). Emesis control by aprepitant in children and adolescents with chemotherapy. International Journal of Clinical Pharmacy. 35(6). 1021–1024. 11 indexed citations
12.
Bauters, Tiene, et al.. (2012). What’s in a drop? Optimizing strategies for administration of drugs in pediatrics. International Journal of Clinical Pharmacy. 34(5). 679–681. 9 indexed citations
13.
Pousset, G, Johan Bilsen, Yves Benoît, et al.. (2009). Attitudes of Adolescent Cancer Survivors Toward End-of-Life Decisions for Minors. PEDIATRICS. 124(6). e1142–e1148. 54 indexed citations
14.
Goethals, Ingeborg, et al.. (2009). Time-dependent changes in 18F-FDG activity in the thymus and bone marrow following combination chemotherapy in paediatric patients with lymphoma. European Journal of Nuclear Medicine and Molecular Imaging. 37(3). 462–467. 17 indexed citations
15.
Bauters, Tiene, Joris Verlooy, Hugo Robays, & Geneviève Laureys. (2008). Interaction between methotrexate and omeprazole in an adolescent with leukemia: a case report. Pharmacy World & Science. 30(4). 316–318. 21 indexed citations
16.
Verlooy, Joris, Véronique Mosseri, Serge Bracard, et al.. (2006). Treatment of high risk medulloblastomas in children above the age of 3 years: A SFOP study. European Journal of Cancer. 42(17). 3004–3014. 56 indexed citations
17.
Maerken, Tom Van, et al.. (2004). Familial and Congenital Polycythemias: A Diagnostic Approach. Journal of Pediatric Hematology/Oncology. 26(7). 407–416. 8 indexed citations
18.
Verlooy, Joris, et al.. (1997). Detection of serum insulin-like growth factor binding proteins on Western ligand blots by biotinylated IGF and enhanced chemiluminescence. Journal of Endocrinology. 154(2). R1–R5. 15 indexed citations
19.
Dams, Erna, et al.. (1995). Instability of microsatellites in human gliomas.. PubMed. 55(7). 1547–9. 62 indexed citations
20.
Verlooy, Joris, et al.. (1989). Transcranial Doppler sonography.. PubMed. 89(2). 87–92. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026